# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k060854   
B. Purpose for Submission: New Device   
C. Measurand: Cholesterol HDL Cholesterol LDL Cholesterol Triglycerides HDL Cholesterol Calibrator LDL Cholesterol Calibrator

. Type of Test: Quantitative immunoturbidimetric and enzymatic photometric assays

E. Applicant: HORIBA ABX

F. Proprietary and Established Names: ABX PENTRA 400: Lipoproteins

# G. Regulatory Information:

1. Regulation section: 21CFR Sec. 862.1150 - Calibrator. 21CFR Sec. 862.1660 - Quality control material (assayed and unassayed). 21CFR Sec. 862.1705 - Triglyceride test system. 21CFR Sec. 862.1175 - Cholesterol (total) test system. 21CFR Sec. 862.1475 - Lipoprotein test system.

2. Classification:

Class II, Class I reserved, and Class I meets the limitations to exemptions 21 CFR $\ S 8 6 2 . 9$ (c) (4)

3. Product code: JIT - Calibrator, Secondary JJY - Multi-Analyte Controls, All Kinds (Assayed and Unassayed) CDT - Lipase Hydrolysis/Glycerol Kinase Enzyme CHH - Enzymatic Esterase--Oxidase, Cholesterol LBR - LDL & VLDL Precipitation, HDL MRR – Low Density Lipoprotein

4. Panel: Chemistry (75)

# H. Intended Use:

1. Intended use(s): See indications for use below.

2. Indication(s) for use:

ABX PENTRA Cholesterol CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of cholesterol in human serum and plasma based on an enzymatic photometric test (Trinder’s reaction).

ABX PENTRA HDL Direct CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of High Density Lipoprotein Cholesterol (HDL-C) in human serum and plasma based on an enzymatic assay with accelerator selective detergent methodology.

ABX PENTRA LDL Direct CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of Low Density Lipoprotein Cholesterol (LDL-C) in human serum and plasma based on an enzymatic colorimetric assay.

Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders.

ABX PENTRA Triglycerides CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of triglycerides in human serum and plasma based on an enzymatic colorimetric assay.

Measurements obtained by this device are used in the diagnosis and treatment of patients with diabetes mellitus, nephrosis, liver obstruction, other diseases involving lipid metabolism, or various endocrine disorders.

The ABX PENTRA HDL Cal is a calibrator for use in the calibration of quantitative Horiba ABX PENTRA HDL Direct CP method on Horiba ABX clinical chemistry analyzers.

The ABX PENTRA LDL Cal is a calibrator for use in the calibration of quantitative Horiba ABX PENTRA LDL Direct CP method on Horiba ABX clinical chemistry analyzers.

3. Special conditions for use statement(s): Prescription Use

4. Special instrument requirements: ABX PENTRA 400 (k052007)

I. Device Description:

ABX Pentra Cholesterol CP is ready-to-use.

Reagent Good’s buffer pH 6.7 50 mmol/L Phenol 5 mmol/L 4-Aminoantipyrine 0.3 mmol/L Cholesterol esterase (CHE) ≥ 200 U/L Cholesterol oxidase (CHO) ≥ 50 U/L Peroxidase (POD) $\ge 3 \mathrm { ~ k U / L ~ }$ Sodium azide $0 . 9 5 \mathrm { g / L }$

ABX Pentra HDL Direct CP is ready-to-use.

Reagent 1 Good’s Buffer Cholesterol oxidase < 1000 U/L Peroxidase < 1300 ppg U/L N,N-bis(4-sulphobutyl)- m- $< 1 ~ \mathrm { m M }$ toluidine- disodium (DSBmT) Accelerator $< 1 ~ \mathrm { m M }$ Preservative $< 0 . 0 6 \%$

Reagent 2 Good’s Buffer Cholesterol esterase 4- < 1500 U/L < Aminoantipyrine (4-AAP) 1mM Detergent < 2 % Restrainer < 0.15% Preservative < 0.06 % Ascorbic acid oxidase $< 3 0 0 0 \mathrm { U / L }$

ABX Pentra LDL Direct CP is ready-to-use.

Reagent 1 MES Buffer $\left( \mathrm { p H } 6 . 3 \right)$ Detergent 1 < 1.0 % Cholesterol Esterase < 1500 U/L Cholesterol Oxidase $< 1 5 0 0 \mathrm { U / L }$ Peroxidase < 1300 ppg U/L 4-aminoantipyrine < 0.1 % Ascorbic Acid Oxidase $< 3 0 0 0 \mathrm { U / L }$ Preservative

Reagent 2 MES Buffer $\left( \mathrm { p H } 6 . 3 \right)$ Detergent 2 < 1.0 % N,N-bis(4-sulfobutyl)-toluidine, $< 1 . 0 \mathrm { m M }$ disodium (DsBmT) Preservative

# ABX Pentra Triglycerides CP is ready-to-use.

Pipes free acid 50 mmol/L Sodium hydroxide 3.36 g/L Triton X-100 1 ml/L Magnesium salt 14.8 mmol/L p-chlorophenol 2.7 mmol/L ATP 3.15 mmol/L Sodium azide 7.99 mmol/L Potassium ferrocyanide 10 μmol/L 4-aminoantipyrine 0.31 mmol/L Lipoprotein lipase ≥ 2000 U/L Glycerokinase $\geq 5 0 0 \mathrm { U } / \mathrm { L }$ Glycerol phosphate Oxidase $\geq 4 0 0 0 \mathrm { U / L }$ Peroxidase $\geq 5 0 0 \mathrm { U } / \mathrm { L }$

ABX Pentra HDL Cal is a lyophilized calibrator. It is a preparation of lyophilized human serum containing lipoproteins from the various lipoprotein classes including high-density lipoproteins.

ABX Pentra LDL Cal is a lyophilized calibrator. It is a preparation of lyophilized human serum containing lipoproteins from the various lipoprotein classes including low-density lipoproteins. • The kit is composed of 2 vials of calibrator (lyophilized for 1 mL)

# J. Substantial Equivalence Information:

1. Predicate device name(s): Roche Cholesterol Reagent Ultra N-Geneous HDL Cholesterol Reagent N-Geneous LDL Cholesterol Reagent Roche Reagent for Triglycerides Roche Apolipoprotein Standard Ultra N-Geneous HDL Cholesterol Reagent Calibrator N-Geneous LDL Cholesterol Reagent Calibrator Liquichek Lipids Control

2. Predicate 510(k) number(s): k941573, k021316, k971573, k893973, k021316, k971573, respectively

3. Comparison with predicate:

<table><tr><td colspan="1" rowspan="1">cYanmaGYellowb</td><td colspan="1" rowspan="1">Predicate device (k941573):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">ABX Pentra Cholesterol CP</td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">Roche, USA</td><td colspan="1" rowspan="1">HORIBA ABX, France</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">COBAS MIRA chemistrysystem</td><td colspan="1" rowspan="1">ABX PENTRA 400</td></tr><tr><td colspan="1" rowspan="1">Analytes</td><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Cholesterol</td></tr><tr><td></td><td>Predicate device (k941573):</td><td>Device :</td></tr><tr><td>Device Name</td><td>Cholesterol</td><td>ABX Pentra Cholesterol CP</td></tr><tr><td>Method : Specimen :</td><td>Enzymatic photometric test Serum</td><td>Enzymatic photometric test Serum</td></tr><tr><td>Certification :</td><td>Plasma Traceability to the National Reference System for</td><td>Plasma Traceability to the National Reference System for</td></tr><tr><td>Component reagent matrices</td><td>Cholesterol Single-reagent bottle, ready to use: REAGENT : 4- Aminoantipyrine, Cholesterol Esterase, Cholesterol Oxidase,</td><td>Cholesterol Mono-reagent cassette, ready to use: REAGENT : Good's buffer, Phenol, 4-Aminoantipyrine, Cholesterol Esterase, Cholesterol Oxidase, Peroxidase, Sodium</td></tr><tr><td>Format Labels</td><td>stabilizers, fillers Liquid</td><td>azide Liquid Horiba ABX specific label</td></tr><tr><td>Packaging</td><td>Single-reagent bottles REAGENT : 15 x 12 ml or 4 x 12 mL</td><td>Mono-reagent cassette : REAGENT : 99 mL</td></tr><tr><td>Controls</td><td>Commercially available quality control (not included): 2 levels of serum-based controls with known cholesterol values</td><td>Recommended quality control material (not included): ABX Pentra N Control (Normal control) ABX Pentra P Control</td></tr><tr><td>Calibrators</td><td>Commercially available calibrator (not included)</td><td>(Pathologic control) Recommended calibration material (not included): ABX Pentra Multical</td></tr><tr><td>Performance data :</td><td></td><td>380 tests</td></tr><tr><td>Number of tests</td><td>3 μL/test</td><td>3 μL/test</td></tr><tr><td>Sample volume</td><td></td><td></td></tr><tr><td>Detection limit</td><td>2 mg/dL CV Total &lt; 2.4%</td><td>4 mg/dL CV Total &lt; 3.01%</td></tr><tr><td>Accuracy and Precision</td><td></td><td></td></tr><tr><td>Measuring range</td><td>2 mg/dL − 525 mg/dL 525 mg/dL (with automatic post-</td><td>2.55 mg/dL − 583.26 mg/dL 580 mg/dL</td></tr><tr><td>Upper linearity limit</td><td>dilution : 1050 mg/dL)</td><td></td></tr><tr><td>Calibration stability</td><td>Calibration required monthly Until the expiration date when</td><td>8 days 24 months at 2-8°C</td></tr><tr><td>Closed reagent</td><td>stored at 2-8°</td><td></td></tr><tr><td>stability</td><td>30 days at 2-8°</td><td>on-board stability (refrigerated area): 48 days</td></tr><tr><td colspan="1" rowspan="1">Open Reagentstability</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Predicate device (k021316):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">Ultra N-geneous® HDLCholesterol Reagent</td><td colspan="1" rowspan="1">ABX Pentra HDL Direct CP</td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">Genzyme, USA</td><td colspan="1" rowspan="1">HORIBA ABX, France</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Automated clinical chemistryanalyzer</td><td colspan="1" rowspan="1">ABX PENTRA 400</td></tr><tr><td colspan="1" rowspan="1">Analytes</td><td colspan="1" rowspan="1">High Density LipoproteinCholesterol (HDL-C)</td><td colspan="1" rowspan="1">High Density LipoproteinCholesterol (HDL-C)</td></tr><tr><td colspan="1" rowspan="1">Method :</td><td colspan="1" rowspan="1">Accelerator Selective detergentMethodology</td><td colspan="1" rowspan="1">Accelerator Selective detergentMethodology</td></tr><tr><td colspan="1" rowspan="1">Specimen :</td><td colspan="1" rowspan="1">SerumPlasma</td><td colspan="1" rowspan="1">SerumPlasma</td></tr><tr><td colspan="1" rowspan="1">Component reagentmatrices</td><td colspan="1" rowspan="1">Single reagent bottles, ready touse:REAGENT 1 : Buffer,Cholesterol oxidase, Peroxidase,N,N-bis(4-sulphobutyl)-m-toluidine-disodium (DSBmT),Accelerator, Preservative,Ascorbic oxidaseREAGENT 2 : Buffer,Cholesterol esterase, 4-Aminoantipyrine (4-AAP),Detergent, Preservative</td><td colspan="1" rowspan="1">Bi-reagent cassette, ready to useREAGENT 1 : Good's buffer,Cholesterol oxidase, Peroxidase,N,N-bis(4-sulphobutyl)-m-toluidine-disodium (DSBmT),Accelerator, PreservativeREAGENT 2 : Good's buffer,Cholesterol esterase, 4-Aminoantipyrine (4-AAP),Detergent, Restrainer,Preservative, Ascorbic acidoxidase</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Liquid</td><td colspan="1" rowspan="1">Liquid</td></tr><tr><td colspan="1" rowspan="1">Labels</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Horiba ABX specific label</td></tr><tr><td colspan="1" rowspan="1">Packaging</td><td colspan="1" rowspan="1">Single-reagent bottlesREAGENT 1 : 1 x 250 mLREAGENT 2 : 1 x 80 mL</td><td colspan="1" rowspan="1">Bi-reagent cassette :REAGENT 1 : 62 mLREAGENT 2 : 21 mL</td></tr><tr><td colspan="1" rowspan="1">Controls</td><td colspan="1" rowspan="1">Recommended qualitycontrol material (not included):Normal and near theconcentrations for decision-making controls</td><td colspan="1" rowspan="1">Recommended quality controlmaterial (not included):ABX Pentra N Control(Normal control)ABX Pentra P Control(Pathologic control)</td></tr><tr><td colspan="1" rowspan="1">Calibrators</td><td colspan="1" rowspan="1">Recommended calibrationmaterial (not included):Ultra N_geneous® HDLCholesterol Calibrator</td><td colspan="1" rowspan="1">Recommended calibrationmaterial (not included):ABX Pentra HDL Cal</td></tr><tr><td colspan="1" rowspan="1">Performance data :Number of testsSample volumeDetection limit</td><td colspan="1" rowspan="1">3 μL/test</td><td colspan="1" rowspan="1">240 tests3 μL/test1.16 mg/dL</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 1.5%</td><td>CV Total &lt; 3.52%</td></tr><tr><td>Measuring range</td><td>33.6 mg/dL − 133 mg/dL</td><td>5.4 mg/dL − 151.9 mg/dL</td></tr><tr><td>Upper linearity limit</td><td>200 mg/dL</td><td>154.8 mg/dL</td></tr><tr><td>Calibration stability</td><td></td><td>14 days</td></tr><tr><td>Closed reagent</td><td>Until the expiration date when stored at 2-8°C</td><td>22 months at 2-8°C</td></tr><tr><td>stability</td><td>4 weeks at 2-8°C</td><td>on-board stability (refrigerated</td></tr><tr><td>Open Reagent stability</td><td></td><td>area): 31 days</td></tr></table>

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Predicate device (k971573):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">N-geneous® LDLCholesterol Reagent</td><td colspan="1" rowspan="1">ABX Pentra LDL Direct CP</td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">Genzyme, USA</td><td colspan="1" rowspan="1">HORIBA ABX, France</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Automated clinical chemistryanalyzer</td><td colspan="1" rowspan="1">ABX PENTRA 400</td></tr><tr><td colspan="1" rowspan="1">Analytes</td><td colspan="1" rowspan="1">Low Density LipoproteinCholesterol (LDL-C)</td><td colspan="1" rowspan="1">Low Density LipoproteinCholesterol (LDL-C)</td></tr><tr><td colspan="1" rowspan="1">Method :</td><td colspan="1" rowspan="1">Enzymatic colorimetric assay</td><td colspan="1" rowspan="1">Enzymatic colorimetric assay</td></tr><tr><td colspan="1" rowspan="1">Specimen :</td><td colspan="1" rowspan="1">SerumPlasma</td><td colspan="1" rowspan="1">SerumPlasma</td></tr><tr><td colspan="1" rowspan="1">Component reagentmatrices</td><td colspan="1" rowspan="1">Single reagent bottles, ready touse:REAGENT 1 : MES buffer,Detergent 1, CholesterolEsterase, Cholesterol Oxidase,Peroxidase, 4-Aminoantipyrine,Ascorbic Acid Oxidase,PreservativeREAGENT 2 : MES buffer,Detergent 2, N,N-bis(4-sulfobutyl)-m-toluidine-disodium (DSBmT),Preservative</td><td colspan="1" rowspan="1">Bi-reagent cassette, ready to useREAGENT 1 : MES buffer,Detergent 1, CholesterolEsterase, Cholesterol Oxidase,Peroxidase, 4-Aminoantipyrine,Ascorbic Acid Oxidase,PreservativeREAGENT 2 : MES buffer,Detergent 2, N,N-bis(4-sulfobutyl)-toluidine-disodium(DSBmT), Preservative,</td></tr><tr><td colspan="1" rowspan="1">Format</td><td colspan="1" rowspan="1">Liquid</td><td colspan="1" rowspan="1">Liquid</td></tr><tr><td colspan="1" rowspan="1">Labels</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1">Horiba ABX specific label</td></tr><tr><td colspan="1" rowspan="1">Packaging</td><td colspan="1" rowspan="1">Single-reagent bottles :REAGENT 1 : 1 x 30 mLREAGENT 2 : 1 x 10 mL</td><td colspan="1" rowspan="1">Bi-reagent cassette :REAGENT 1 : 28 mLREAGENT 2 : 10 mL</td></tr><tr><td>Device Name</td><td>N-geneous® LDL Cholesterol Reagent</td><td>ABX Pentra LDL Direct CP</td></tr><tr><td>Controls</td><td>Commercially available quality</td><td>Recommended quality control</td></tr><tr><td></td><td>control material (not included)</td><td>material (not included): ABX Pentra N Control (Normal control) ABX Pentra P Control (Pathologic control)</td></tr><tr><td>Calibrators Performance data :</td><td>Recommended calibration material (not included): N_geneous® LDL Cholesterol Calibrator</td><td>Recommended calibration material (not included): ABX Pentra LDL Cal</td></tr><tr><td>Number of tests Sample volume Detection limit</td><td>3 μL/test 0.278 mg/dL</td><td>100 tests 2.4 μL/test 1.55 mg/dL</td></tr><tr><td>Analytical sensitivity Accuracy and Precision Measuring range Upper linearity limit</td><td>CV Total &lt; 2.27% 6.6 mg/dL − 992 mg/dL 992 mg/dL</td><td>CV Total &lt; 6.39% 1.35 mg/dL  369.39 mg/dL 387 mg/dL</td></tr></table>

<table><tr><td colspan="1" rowspan="1">cYanmaGYellowb</td><td colspan="1" rowspan="1">Predicate device (k893973):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">Triglycerides</td><td colspan="1" rowspan="1">ABX Pentra TriglyceridesCP</td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">Roche, USA</td><td colspan="1" rowspan="1">HORIBA ABX, France</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">COBAS chemistry system</td><td colspan="1" rowspan="1">ABX PENTRA 400</td></tr><tr><td colspan="1" rowspan="1">Analytes</td><td colspan="1" rowspan="1">Triglycerides</td><td colspan="1" rowspan="1">Triglycerides</td></tr><tr><td colspan="1" rowspan="1">Method :</td><td colspan="1" rowspan="1">Enzymatic colorimetric assay</td><td colspan="1" rowspan="1">Enzymatic colorimetric assay</td></tr><tr><td colspan="1" rowspan="1">Specimen :</td><td colspan="1" rowspan="1">SerumPlasma</td><td colspan="1" rowspan="1">SerumPlasma</td></tr><tr><td colspan="1" rowspan="1">Component reagentmatrices</td><td colspan="1" rowspan="1">Single reagent bottles, thecombined reagents contain the</td><td colspan="1" rowspan="1">Mono-reagent cassette, ready touse</td></tr><tr><td></td><td>Predicate device (k893973):</td><td>Device :</td></tr><tr><td>Device Name</td><td>Triglycerides</td><td>ABX Pentra Triglycerides CP</td></tr><tr><td></td><td>following components: ATP, 4-Aminoantipyrine, Glycerol kinase, Glycerol phosphate oxidase, Lipases, Peroxidase, Sodium N-Ethyl-N- (3-Sulfopropyl)-m-anisidine (ESPAS), buffers, stabilizers,</td><td>REAGENT : Pipes free acid, Sodium hydroxide, Triton X- 100, Magnesium salt, p- chlorophenol, ATP, Sodium azide, Potassium ferrocyanide, 4-Aminoantipyrine, Lipoprotein lipase, Glycerokinase, Glycerol</td></tr><tr><td>Format</td><td>fillers Liquid</td><td>phosphate Oxidase, Peroxidase Liquid</td></tr><tr><td>Labels Packaging</td><td>Kit composed of single-reagent</td><td>Horiba ABX specific label Mono-reagent cassette :</td></tr><tr><td></td><td>bottles REAGENT 1 : 2 x 80 mL REAGENT 2 : 2 x 40 ml</td><td>REAGENT : 99 mL</td></tr><tr><td>Controls</td><td>Commercially available quality control (not included): 2 levels</td><td>Recommended quality control material (not included): ABX Pentra N Control (Normal control) ABX Pentra P Control</td></tr><tr><td>Calibrators</td><td>Commercially available calibrator (not included)</td><td>(Pathologic control) Recommended calibration material (not included): ABX Pentra Multical</td></tr><tr><td>Additional Reagents</td><td></td><td>Cleaning solution (not included): ABX Pentra Clean-Chem CP / ABX Pentra Clean-Chem 99 CP</td></tr><tr><td>Performance data :</td><td></td><td></td></tr><tr><td>Number of tests</td><td></td><td>327 tests</td></tr><tr><td>Sample volume</td><td>4 μL/test</td><td>3 μL/test</td></tr><tr><td>Detection limit</td><td></td><td>7 mg/dL</td></tr><tr><td>Accuracy and Precision</td><td>CV Total &lt; 3.6%</td><td>CV Total &lt; 2.83%</td></tr><tr><td>Measuring range</td><td>10 mg/dL - 662 mg/dL 900 mg/dL (with automatic post-</td><td>3.1 mg/dL − 1434 mg/dL</td></tr><tr><td>Upper linearity limit</td><td>dilution : 1800 mg/dL)</td><td>1470 mg/dL, with an automatique post-dilution : 5580 mg/dL</td></tr><tr><td>Calibration stability</td><td>Until the expiration date when stored at 2-8°</td><td>14 days 16 months at 2-8°</td></tr><tr><td>Closed reagent stability</td><td>Combined reagent is stable:</td><td></td></tr><tr><td>Open Reagent</td><td>1 year at 2-8° 60 days at room temperature</td><td>on-board stability (refrigerated area): 48 days</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">Triglycerides</td><td colspan="1" rowspan="1">ABX Pentra TriglyceridesCP</td></tr><tr><td colspan="1" rowspan="1">stability</td><td colspan="1" rowspan="1">(15-25°C)</td><td colspan="1" rowspan="1"></td></tr></table>

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Predicate device (k021316):</td><td rowspan=1 colspan=1>Device :</td></tr><tr><td rowspan=1 colspan=1>Device Name</td><td rowspan=1 colspan=1>Ultra N-geneous® HDLCholesterol Calibrator</td><td rowspan=1 colspan=1>ABX Pentra HDL Cal</td></tr><tr><td rowspan=1 colspan=1>Manufactured by</td><td rowspan=1 colspan=1>Genzyme, USA</td><td rowspan=1 colspan=1>HORIBA ABX, France</td></tr><tr><td rowspan=1 colspan=1>Instrument</td><td rowspan=1 colspan=1>Chemistry systems</td><td rowspan=1 colspan=1>ABX PENTRA 400</td></tr><tr><td rowspan=1 colspan=1>Method :</td><td rowspan=1 colspan=1>Calibration of Genzyme Ultra N-geneous HDL Cholesterol assay</td><td rowspan=1 colspan=1>Calibration of HORIBA ABXHDL Cholesterol measurementmethod</td></tr><tr><td rowspan=1 colspan=1>Component matrices</td><td rowspan=1 colspan=1>Vials (lyophilized)Human serum based</td><td rowspan=1 colspan=1>Vials (lyophilized)Human serum based, withpreservative</td></tr><tr><td rowspan=1 colspan=1>Calibrated molecules</td><td rowspan=1 colspan=1>HDL Cholesterol</td><td rowspan=1 colspan=1>HDL Cholesterol</td></tr><tr><td rowspan=1 colspan=1>Format</td><td rowspan=1 colspan=1>Lyophilized</td><td rowspan=1 colspan=1>Lyophilized</td></tr><tr><td rowspan=1 colspan=1>Labels</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>Horiba ABX specific label</td></tr><tr><td rowspan=1 colspan=1>Packaging</td><td rowspan=1 colspan=1>Kit composed of :1 x 1 mL vial</td><td rowspan=1 colspan=1>Kit composed of :2 x 1 mL vial</td></tr><tr><td rowspan=1 colspan=1>Performance data :Calibration valueClosed stabilityOpen stability</td><td rowspan=1 colspan=1>- Assigned by procedurestraceable to the NationalReference System forCholesterol (NRS/CHOL)- The concentration ofcomponent is given on the viallabelUp to the expiration date at 2-814 days at 2-8°4 weeks at −70°</td><td rowspan=1 colspan=1>- Assigned by procedurestraceable to the NationalReference System forCholesterol (NRS/CHOL)- The concentration ofcomponent is lot specific- The concentration is given inthe enclosed annex24 months at 2-8°C14 days at 2-8°C4 weeks at −70°C</td></tr></table>

<table><tr><td colspan="1" rowspan="1">cYanmaGellowb</td><td colspan="1" rowspan="1">Predicate device (k971573):</td><td colspan="1" rowspan="1">Device :</td></tr><tr><td colspan="1" rowspan="1">Device Name</td><td colspan="1" rowspan="1">N-geneousTM LDLCholesterol Calibrator</td><td colspan="1" rowspan="1">ABX Pentra LDL Cal</td></tr><tr><td colspan="1" rowspan="1">Manufactured by</td><td colspan="1" rowspan="1">Genzyme, USA</td><td colspan="1" rowspan="1">HORIBA ABX, France</td></tr><tr><td colspan="1" rowspan="1">Instrument</td><td colspan="1" rowspan="1">Chemistry systems</td><td colspan="1" rowspan="1">ABX PENTRA 400</td></tr><tr><td colspan="1" rowspan="1">Method :</td><td colspan="1" rowspan="1">Calibration of Genzyme N-</td><td colspan="1" rowspan="1">Calibration of HORIBA ABX</td></tr><tr><td></td><td>Predicate device (k971573):</td><td>Device :</td></tr><tr><td>Device Name</td><td>N-geneousTM LDL Cholesterol Calibrator</td><td>ABX Pentra LDL Cal</td></tr><tr><td></td><td>geneous LDL Cholesterol assay</td><td>LDL Cholesterol measurement method</td></tr><tr><td>Component matrices</td><td>Vials (lyophilized) Human serum based</td><td>Vials (lyophilized) Human serum based, with preservative</td></tr><tr><td>Calibrated molecules</td><td>LDL Cholesterol</td><td>LDL Cholesterol</td></tr><tr><td>Format</td><td>Lyophilized</td><td>Lyophilized</td></tr><tr><td>Labels</td><td>-</td><td>Horiba ABX specific label</td></tr><tr><td>Packaging</td><td>Kit composed of : 1 x 1 mL vial</td><td>Kit composed of : 2 x 1 mL vial</td></tr><tr><td>Performance data : Calibration value</td><td>- Assigned by procedures traceable to the National Reference System for Cholesterol (NRS/CHOL)</td><td>- Assigned by procedures traceable to the National Reference System for Cholesterol (NRS/CHOL) - The concentration of component is lot specific</td></tr><tr><td></td><td>- The concentration of component is given on the vial label</td><td>- The concentration is given in the enclosed annex</td></tr><tr><td>Closed stability</td><td>Up to the expiration date at 2- 8</td><td>24 months at 2-8°C</td></tr><tr><td>Open stability</td><td>2 weeks at 2-8°C</td><td>2 weeks at 2-8°C</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

CLSI - Evaluation of Precision Performance of Clinical Chemistry Devices; Approved   
Guideline-Second Edition - EP05-A2   
CLSI - Evaluation of the Linearity of Quantitative Analytical Methods; Approved   
Guideline - EP06-A   
CLSI - Method Comparison and Bias Estimation Using Patient Samples; Approved   
Guideline - Second Edition - EP09-A2

# L. Test Principle: ABX PENTRA Cholesterol CP

’’CHOD-PAP’’: enzymatic photometric test.

Determination of cholesterol after enzymatic hydrolysis and oxidation (3,4). The colorimetric indicator is quinoneimine which is generated from 4-aminoantipyrine and phenol by hydrogen peroxide under the catalytic action of peroxidase (Trinder’s reaction)

# ABX PENTRA HDL Direct CP

The assay is a homogeneous method for directly measuring HDL-C levels in serum or plasma without the need for any off-line pretreatment or centrifugation steps.

The method is in a two reagent format and depends on the properties of a unique detergent, as illustrated. This method is based on accelerating the reaction of cholesterol oxidase (CO) with non-HDL unesterified cholesterol and dissolving HDL selectively using a specific detergent.

In the first reagent, non-HDL unesterified cholesterol is subject to an enzyme reaction and the peroxide generated is consumed by a peroxidase reaction with DSBmT yielding a colorless product.

The second reagent consists of a detergent capable of solubilizing HDL specifically, cholesterol esterase (CE) and chromagenic coupler to develop color for the quantitative determination of HDL-C.

# ABX PENTRA LDL Direct CP

The assay is an homogeneous method for directly measuring LDL-C levels in serum or plasma, without the need for any off-line pretreatment or centrifugation steps.

The method is in a two reagent format and depends on the properties of a unique detergent. This detergent (Reagent 1) solubilizes only the non LDL lipoprotein particles. The cholesterol released is consumed by cholesterol esterase and cholesterol oxidase in a non color forming reaction. A second detergent (Reagent 2) solubilizes the remaining LDL particles and a chromogenic coupler allows for color formation. The enzyme reaction with LDL-C in the presence of the coupler produces color that is proportional to the amount of LDL cholesterol present in the sample.

# ABX PENTRA Triglycerides CP

Enzymatic determination of triglycerides according to the following reactions:

Lipoprotein lipase Triglycerides + H2O Glycerol $^ +$ fatty acids > Glycerokinase Glycerol $^ +$ ATP Glycerol-3-phosphate $^ +$ ADP Glycerol-3-phosphate Oxidase Glycerol-3-Phosphate $+ \mathrm { O } _ { 2 }$ H2O2 + DHAP Peroxidase $2 \mathrm { H } _ { 2 } \mathrm { O } _ { 2 } + 4 { \ - \mathrm { A A P } } + \mathrm { p }$ -Chlorophenol Quinoneimine $+ 4 \mathrm { H } _ { 2 } \mathrm { O }$ $( { \mathrm { D H A P } } = \mathbf { I }$ Dihydroxyacetone phosphate, ${ \sf 4 - A A P } = 4$ -aminoantipyrine)

# M. Performance Characteristics (if/when applicable):

1. Analytical performance: a. Precision/Reproducibility: ABX PENTRA Cholesterol CP

Two control materials and three specimens were tested 20times in a single run.   
The results are presented in the table below.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean valuemg/dL</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Normal control</td><td rowspan=1 colspan=1>113</td><td rowspan=1 colspan=1>0.82</td></tr><tr><td rowspan=1 colspan=1>Pathological control</td><td rowspan=1 colspan=1>186</td><td rowspan=1 colspan=1>0.74</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>117</td><td rowspan=1 colspan=1>1.21</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>191</td><td rowspan=1 colspan=1>0.53</td></tr><tr><td rowspan=1 colspan=1>Specimen 3</td><td rowspan=1 colspan=1>389</td><td rowspan=1 colspan=1>0.62</td></tr></table>

In accordance with CLSI guideline EP-5A, two control materials and two specimens were tested in duplicate for 20 days, two times a day $\left( \mathrm { N } { = } 8 0 \right)$ ). The results are presented in the table below.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean valuemg/dL</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Normal control</td><td rowspan=1 colspan=1>109</td><td rowspan=1 colspan=1>2.96</td></tr><tr><td rowspan=1 colspan=1>Pathological control</td><td rowspan=1 colspan=1>183</td><td rowspan=1 colspan=1>2.34</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>170</td><td rowspan=1 colspan=1>2.80</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>3.01</td></tr></table>

# ABX PENTRA HDL Direct CP

Two control materials and three specimens were tested 20times in a single run.   
The results are presented in the table below.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean valuemg/dL</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Normal control</td><td rowspan=1 colspan=1>35.82</td><td rowspan=1 colspan=1>1.29</td></tr><tr><td rowspan=1 colspan=1>Pathological control</td><td rowspan=1 colspan=1>81.72</td><td rowspan=1 colspan=1>0.79</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>27.94</td><td rowspan=1 colspan=1>1.32</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>48.59</td><td rowspan=1 colspan=1>1.91</td></tr><tr><td rowspan=1 colspan=1>Specimen 3</td><td rowspan=1 colspan=1>97.39</td><td rowspan=1 colspan=1>0.62</td></tr></table>

In accordance with CLSI guideline EP-5A, two control materials and two specimens were tested in duplicate for 20 days, two times a day $( \mathrm { N } { = } 8 0 )$ ). The results are presented in the table below.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean valuemg/dL</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Normal control</td><td rowspan=1 colspan=1>35.83</td><td rowspan=1 colspan=1>2.88</td></tr><tr><td rowspan=1 colspan=1>Pathological control</td><td rowspan=1 colspan=1>80.35</td><td rowspan=1 colspan=1>3.06</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>47.07</td><td rowspan=1 colspan=1>3.52</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>80.16</td><td rowspan=1 colspan=1>2.69</td></tr></table>

# ABX PENTRA LDL Direct CP

Two control materials and three specimens were tested 20times in a single run.   
The results are presented in the table below.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean valuemg/dL</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Normal control</td><td rowspan=1 colspan=1>61.26</td><td rowspan=1 colspan=1>1.01</td></tr><tr><td rowspan=1 colspan=1>Pathological control</td><td rowspan=1 colspan=1>75.08</td><td rowspan=1 colspan=1>2.82</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>111.26</td><td rowspan=1 colspan=1>0.91</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>141.45</td><td rowspan=1 colspan=1>1.00</td></tr><tr><td rowspan=1 colspan=1>Specimen 3</td><td rowspan=1 colspan=1>191.16</td><td rowspan=1 colspan=1>0.63</td></tr></table>

In accordance with CLSI guideline EP-5A, two control materials and two specimens were tested in duplicate for 20 days, two times a day $\left( \mathrm { N } { = } 8 0 \right)$ ). The results are presented in the table below.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean valuemg/dl</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Normal control</td><td rowspan=1 colspan=1>60.64</td><td rowspan=1 colspan=1>5.59</td></tr><tr><td rowspan=1 colspan=1>Pathological control</td><td rowspan=1 colspan=1>74.27</td><td rowspan=1 colspan=1>6.39</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>156.58</td><td rowspan=1 colspan=1>3.94</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>191.62</td><td rowspan=1 colspan=1>4.04</td></tr></table>

# ABX PENTRA Triglycerides CP

Two control materials and three specimens were tested 20times in a single run.   
The results are presented in the table below.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean valuemg/dL</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Normal control</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>2.52</td></tr><tr><td rowspan=1 colspan=1>Pathological control</td><td rowspan=1 colspan=1>214</td><td rowspan=1 colspan=1>0.82</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>60</td><td rowspan=1 colspan=1>2.83</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>108</td><td rowspan=1 colspan=1>1.84</td></tr><tr><td rowspan=1 colspan=1>Specimen 3</td><td rowspan=1 colspan=1>232</td><td rowspan=1 colspan=1>1.00</td></tr></table>

In accordance with CLSI guideline EP-5A, two control materials and two specimens were tested in duplicate for 20 days, two times a day $( \mathrm { N } { = } 8 0 )$ ). The results are presented in the table below.

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Mean valuemg/dL</td><td rowspan=1 colspan=1>CV %</td></tr><tr><td rowspan=1 colspan=1>Normal control</td><td rowspan=1 colspan=1>128</td><td rowspan=1 colspan=1>1.91</td></tr><tr><td rowspan=1 colspan=1>Pathological control</td><td rowspan=1 colspan=1>216</td><td rowspan=1 colspan=1>1.70</td></tr><tr><td rowspan=1 colspan=1>Specimen 1</td><td rowspan=1 colspan=1>132</td><td rowspan=1 colspan=1>1.57</td></tr><tr><td rowspan=1 colspan=1>Specimen 2</td><td rowspan=1 colspan=1>243</td><td rowspan=1 colspan=1>1.37</td></tr></table>

b. Linearity/assay reportable range:

The reagent linearity is determined according to the recommendations found in the CLSI (NCCLS), EP6-A protocol. As a result of the testing, the following represent the linear range for each assay.

# ABX PENTRA Cholesterol CP

Low linearity: $4 \mathrm { m g / d L }$ High linearity: $5 8 0 ~ \mathrm { m g / d L }$

ABX PENTRA HDL Direct CP Low linearity: $1 . 1 6 \ : \mathrm { m g / d L }$ High linearity: $1 5 4 . 8 ~ \mathrm { m g / d L }$ .

ABX PENTRA LDL Direct CP Low linearity: $1 . 5 5 \mathrm { m g / d L }$ High linearity: $3 8 7 \mathrm { m g / d L }$

ABX PENTRA Triglycerides CP

Low linearity: $7 \mathrm { m g / d L }$ High linearity: $1 4 7 0 \mathrm { m g / d L }$ , with automatic post-dilution: $5 8 8 0 \mathrm { m g / d L }$

c. Traceability, Stability, Expected values (controls, calibrators, or methods): Calibrators for Cholesterol and Triglyceride, and controls for Cholesterol, HDL, LDL and Triglyceride see k052007.

ABX PENTRA and HDL, LDL Calibrators and L/H Controls Real time stability at $2 { - } 8 ^ { \circ } \mathrm { C }$ was investigated for Calibrator, High Controls and Low Controls.

Real time stability study on reconstituted material was performed at regular intervals over a period providing data to support claims at $2 { - } 8 ^ { \circ } \mathrm { C }$ (All) and – $2 0 \mathrm { { } ^ { \circ } C }$ (Lipoproteins), and – $7 0 \mathrm { { } ^ { \circ } C }$ (HDL).

Traceability

# ABX PENTRA Cholesterol CP Certification

Traceability to the National Reference System for Cholesterol was established by performing a direct comparison with the cholesterol reference method using human specimens that cover the National Cholesterol Education Program (NCEP) medical decision points. The ability to meet the NCEP’s performance criteria for accuracy was demonstrated through testing and certification by the Cholesterol Reference Method Laboratory Network (CRMLN).

The results of the direct comparison and precision studies are as follows: Among-run $\% C V : 1 . 5 \%$ Average $\% \mathrm { B i a s } : - 2 . 5 \%$ Total Error : $5 . 6 \%$

# d. Detection limit:

# ABX PENTRA Cholesterol CP:

Minimum Detection Limit (MDL) is calculated from 30 measurements of saline. Formula: $\mathrm { { \cal M D L } = }$ mean of measurements $+ 4 . 6 5$ SD (mean of   
measurement $= 0$ when negative)   
From the MDL value, the minimum detection limit assigned for this method is 4 $\mathrm { m g / d L }$ .

# ABX PENTRA HDL Direct CP

From the MDL value, the test range low assigned for this method is $1 . 1 6 \ : \mathrm { m g / d L }$

# ABX PENTRA LDL Direct CP

From the MDL value, the test range low assigned for this method is $1 . 5 5 \mathrm { m g / d L }$

# ABX PENTRA Triglycerides CP

From the MDL value, the test range low assigned for this method is $7 \mathrm { m g / d L }$ .

e. Analytical specificity:

ABX PENTRA Cholesterol CP

Hemoglobin: No significant influence is observed up to $3 3 6 \mathrm { m g / d L }$   
Triglycerides: No significant influence is observed up to $6 1 2 . 5 ~ \mathrm { m g / d L }$   
(as Intralipid $^ \mathrm { \textregistered }$ , representative of lipemia)   
Total Bilirubin: No significant influence is observed up to $2 0 . 5 \ : \mathrm { m g / d L }$ Direct Bilirubin: No significant influence is observed up to $6 . 8 \mathrm { m g / d L }$   
Other limitations are given by way of literature reference known to affect this methodology.

# ABX PENTRA HDL Direct CP

Hemoglobin: No significant influence is observed up to $4 7 9 \mathrm { m g / d l }$ . Triglycerides: No significant influence is observed up to $6 1 2 . 5 ~ \mathrm { m g / d L }$ . (as Intralipid $^ \mathrm { \textregistered }$ , representative of lipemia) Total Bilirubin: No significant influence is observed up to $1 1 . 7 \mathrm { m g / d l }$ . Direct Bilirubin: No significant influence is observed up to $2 8 . 1 \mathrm { m g / d l }$

# ABX PENTRA LDL Direct CP

Hemoglobin: No significant influence is observed up to $3 3 6 \mathrm { m g / d l }$ .   
Triglycerides: No significant influence is observed up to $6 1 2 . 5 ~ \mathrm { m g / d L }$ .   
(as Intralipid $^ \mathrm { \textregistered }$ , representative of lipemia) Total Bilirubin: No significant influence is observed up to $2 9 . 2 \mathrm { m g / d l }$ .   
Direct Bilirubin: No significant influence is observed up to $1 0 . 8 \mathrm { m g / d l }$ .

# ABX PENTRA Triglycerides CP

Hemoglobin: No significant influence is observed up to $5 0 0 \mathrm { m g / d l }$ Total Bilirubin: No significant influence is observed up to $2 2 . 5 \mathrm { m g / d l }$ Direct Bilirubin: No significant influence is observed up to $2 2 . 5 \mathrm { m g / d l }$

f. Assay cut-off: Not Applicable

2. Comparison studies:

a. Method comparison with predicate device: ABX PENTRA Cholesterol CP 135 patient samples (serum) are correlated with a commercial reagent taken as reference according to the recommendations found in the

CLSI (NCCLS), EP9-A2 protocol. Values ranged from 2.55 to 583.26 $\mathrm { m g / d L }$ .

The equation for the regression line obtained is: $\mathrm { Y } = 0 . 9 5 \mathrm { x } + 1 . 9 0$ with a correlation coefficient $\mathrm { r } ^ { 2 } = 0 . 9 9 4 3$

# ABX PENTRA HDL Direct CP

121 patient samples are correlated with a commercial reagent taken as reference according to the recommendations found in the CLSI (NCCLS), EP9-A2 protocol. Values ranged from 3.5 to $1 5 5 . 3 \mathrm { m g / d L }$

The equation for the regression line obtained is: $\mathrm { Y } = 0 . 9 1 \mathrm { x } + 1 . 9 8$ with a correlation coefficient $\mathrm { r } ^ { 2 } = 0 . 9 7 6 8$

# ABX PENTRA LDL Direct CP

122 patient samples are correlated with a commercial reagent taken as reference according to the recommendations found in the CLSI (NCCLS), EP9-A2 protocol. Values ranged from 0.3 to $3 8 5 . 6 \mathrm { m g / d L }$

The equation for the regression line obtained is: $\mathrm { Y } = 0 . 9 6 \mathrm { x } - 0 . 2 1$ , with a correlation coefficient $\mathrm { r } ^ { 2 } { = } 0 . 9 9 6 3$

# ABX PENTRA Triglycerides CP

135 patient samples are correlated with a commercial reagent taken as reference according to the recommendations found in the CLSI (NCCLS), EP9-A2 protocol. Values ranged from 8.2 to $2 7 4 . 2 \ : \mathrm { m g / d L }$ The equation for the regression line obtained is: $\mathrm { Y } = 0 . 9 9 \mathrm { x } + 0 . 2 0$ , with a correlation coefficient $\mathrm { r } ^ { 2 } = 0 . 9 9 9 4$

$b$ . Matrix comparison:

# ABX PENTRA Cholesterol CP

To demonstrate equivalence of Cholesterol results in serum and Plasma Heparin-Lithium samples, comparison study was performed. 40 samples $\mathrm { ( 1 0 3 - 3 7 3 ~ m g / d L ) }$ ) were evaluated on Pentra 400 analyzer using ABX Pentra Cholesterol CP reagent.

The equation for the regression line obtained is: $\mathrm { Y } = 0 . 9 9 0 3 \mathrm { x } + 1 . 8 4 6 7$ with a correlation coefficient $\mathrm { r } = 0 . 9 9 6$

# ABX PENTRA HDL Direct CP

To demonstrate equivalence of HDL Cholesterol results in serum and Plasma Heparin-Lithium samples, comparison study was performed. 43 samples $3 5 { \mathrm { - } } 1 1 8 \ \mathrm { m g / d L } )$ were evaluated on Pentra 400 analyzer using ABX Pentra HDL Direct CP reagent.

The equation for the regression line obtained is: $\mathrm { Y } = 0 . 9 4 6 7 \mathrm { x } + 1 . 5 2 5 2$ with a correlation coefficient $\mathrm { r } = 0 . 9 9 6$

# ABX PENTRA LDL Direct CP

To demonstrate equivalence of LDL Cholesterol results in serum and Plasma Heparin-Lithium samples, comparison study was performed. 41 samples $\mathrm { ~ } 5 3 { - } 3 6 2 \mathrm { m g / d L } )$ were evaluated on Pentra 400 analyzer using ABX Pentra LDL Direct CP reagent.

The equation for the regression line obtained is:

# ABX PENTRA Triglycerides CP

To demonstrate equivalence of Triglycerides results in serum and Plasma Heparin-Lithium samples, comparison study was performed. 41 samples $( 4 7 { - } 7 2 8 \ \mathrm { m g / d L } )$ were evaluated on Pentra 400 analyzer using ABX Pentra Triglycerides CP reagent.   
The equation for the regression line obtained is:   
$\mathrm { Y } = 0 . 9 6 9 4 \mathrm { x } - 1 . 7 7 1 7$ with a correlation coefficient $\mathrm { r } = 0 . 9 9 9$

3. Clinical studies:

a. Clinical Sensitivity: Not Applicable   
b. Clinical specificity: Not Applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not Applicable

4. Clinical cut-off: Not Applicable

5. Expected values/Reference range:

# ABX PENTRA Cholesterol CP

Desirable: $< 2 0 0 ~ \mathrm { m g / d L }$   
Borderline high risk: $2 0 0 - 2 3 9 \mathrm { m g / d L }$   
High risk: $> 2 4 0 ~ \mathrm { m g / d L }$   
Cholesterol Education Program (NCEP) medical decision points

# ABX PENTRA HDL Direct CP

Men: $3 0 - 7 0 \mathrm { m g / d L }$   
Women: $3 0 - 8 5 \mathrm { m g / d L }$ (literature)   
According to the NCEP, HDL values greater than or equal to $4 0 \mathrm { m g / d L }$ are   
considered desirable, and values greater than or equal to $6 0 \mathrm { m g / d L }$ are considered to offer some protection against coronary heart disease. Values below $4 0 \mathrm { m g / d L }$ are considered to be a significant independent risk factor for coronary heart disease.

# ABX PENTRA LDL Direct CP

The following NCEP cut-points for patient classification are used for the prevention and management of coronary heart disease.

LDL Cholesterol Classification $< 1 3 0 \mathrm { m g / d L }$ Desirable $1 3 0 { \mathrm { - } } 1 5 9 \ \mathrm { m g / d L }$ Borderline High Risk $1 6 0 \mathrm { m g / d L }$ High Risk

# ABX PENTRA Triglycerides CP

The following NCEP cut- points been classified according to the risk of developing cardiovascular diseases:

Normal: $< 1 5 0 ~ \mathrm { m g / d L }$ Low risk: $1 5 0 - 2 0 0 \mathrm { m g / d L }$ High: $2 0 0 - 5 0 0 ~ \mathrm { { m g / d L } }$ Extremely high: $> 5 0 0 ~ \mathrm { m g / d L }$

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.